Private history
Your goals, symptoms, medicines, pregnancies, infections, pelvic procedures and relevant health history are discussed without judgement.

An elective injection-based procedure intended to add temporary prominence to a selected area of the anterior vaginal wall. Because anatomy and outcomes vary—and the evidence remains limited—suitability is discussed honestly, never assumed.
Important: this procedure cannot promise increased sensitivity, orgasm or sexual satisfaction. Consultation also considers whether another medical, pelvic-floor, hormonal or psychosexual assessment would be more appropriate.


Enquiries, examination and records are handled discreetly. A female chaperone is arranged by default, and no examination, photograph or procedure occurs without explicit consent.
G-spot enhancement—also called G-spot augmentation, a G-shot or anterior vaginal-wall augmentation—is a cosmetic term for placing a small amount of injectable material into a carefully selected area of the front vaginal wall. The intent is to make that area temporarily more prominent during pressure or contact.
The term “G-spot” is familiar to patients, but medical research does not agree that it is a single, separate structure with one predictable location. A more cautious explanation is that some individuals report a sensitive region within the anterior vaginal wall, possibly related to the broader clitoral–urethral–vaginal tissue complex.
Reduced arousal, difficulty reaching orgasm, pain, dryness, low desire and urinary symptoms can have very different causes. A focal injection is not an appropriate substitute for diagnosing hormonal, gynaecological, pelvic-floor, medication-related, psychological or relationship factors.
A 2021 systematic review found no scientific agreement on the existence, location, size or nature of a discrete G-spot. Professional guidance on elective genital cosmetic procedures advises clinicians to explain the lack of high-quality effectiveness data and the potential complications.
The safest consultation separates a very specific elective request from symptoms that deserve another type of assessment.
There should be enough time to understand the concern, rule out other causes, and decide whether doing nothing is the better choice.
Your goals, symptoms, medicines, pregnancies, infections, pelvic procedures and relevant health history are discussed without judgement.
An intimate examination is performed only when needed, with a female chaperone by default and permission at every stage.
Evidence limits, alternatives, injectable choice, realistic goals, cost factors, aftercare and reasons not to proceed are reviewed.
Under local anaesthesia, a selected product may be placed in a carefully assessed anterior vaginal-wall area using a conservative plan.
You receive written instructions, activity guidance and red-flag symptoms that require urgent contact with the clinic.
These terms are often mixed together online, but they are not the same intervention and they should not be sold as interchangeable solutions.
Usually refers to adding temporary prominence with a selected injectable filler in an anterior vaginal-wall area.
Key limitation: a volume change does not guarantee a functional or sexual-response change.
Uses platelet-rich plasma prepared from the patient’s own blood and injected into selected intimate tissues.
Key limitation: protocols vary and evidence for predictable sexual or urinary benefits remains limited.
May include gynaecological review, pelvic-floor physiotherapy, menopause care, medication review or psychosexual support.
Key benefit: treatment is matched to the actual cause rather than a marketing label.
The following factors may require treatment of another condition first, additional specialist review, or a decision not to perform the injection.
Elective treatment is generally postponed during pregnancy and until recovery and hormonal changes have been appropriately reviewed.
Vaginal discharge, urinary infection, sores, fever, bleeding or irritation require diagnosis and treatment before any cosmetic injection.
Dyspareunia, vaginismus, vulvodynia or pelvic pain should not be managed with a filler without cause-focused evaluation.
Anticoagulants, clotting disorders, uncontrolled diabetes, immune problems or poor healing may change or prevent treatment.
Previous filler complications, hypersensitivity, inflammatory disease or an unknown prior product need careful review.
The procedure is not appropriate when there is coercion, relationship pressure, a demand for guaranteed orgasm or inability to accept uncertainty.
“Non-surgical” does not mean risk-free. The anterior vaginal wall is close to the urethra and contains variable vascular and nerve anatomy.
Written aftercare should explain what is expected and what is not. Seek prompt medical advice for:
For severe breathlessness, chest pain, collapse or another emergency, attend the nearest emergency department immediately rather than waiting for an online reply.
The quality of this consultation depends on discretion, medical judgement and the willingness to advise against treatment when the likely benefit is unclear.
Our consultation standard: normal anatomical variation is respected; a female chaperone is arranged by default; no patient photographs are taken without separate written consent; and sexual satisfaction is never presented as a guaranteed medical outcome.
Direct answers about evidence, privacy, procedure planning, recovery and limitations.
G-spot enhancement, also called G-spot augmentation or a G-shot, is an elective injection-based procedure intended to add temporary prominence to a selected area of the anterior vaginal wall. It is not a medically necessary treatment and it does not create a new anatomical structure.
No single, consistently located anatomical structure has been universally confirmed. Some researchers describe a sensitive anterior vaginal-wall region or a broader clitoral–urethral–vaginal complex, while other anatomical studies have not identified a discrete G-spot.
No. Sexual response is influenced by anatomy, hormones, health, medication, pelvic-floor function, emotional wellbeing and relationship factors. The procedure cannot guarantee increased sensitivity, easier orgasm or improved sexual satisfaction.
When considered appropriate, a small amount of a selected injectable—commonly a hyaluronic-acid-based filler in cosmetic practice—may be placed beneath the mucosa of a carefully assessed anterior vaginal-wall area under local anaesthesia. The exact product, depth and volume require individual medical judgement.
No. G-spot enhancement usually refers to volume augmentation with an injectable filler. An O-Shot-type procedure uses platelet-rich plasma prepared from the patient’s blood. They have different materials, proposed mechanisms and evidence limitations.
An adult seeking an informed discussion about a personally identified sensitive anterior vaginal-wall area may request consultation. Suitability depends on medical history, examination, realistic expectations and understanding that benefit is uncertain.
Treatment is generally deferred in pregnancy, during active genital or urinary infection, with unexplained bleeding, significant pelvic pain, an untreated pelvic-floor or gynaecological condition, relevant allergy, uncontrolled medical illness or when expectations cannot be met safely.
Local anaesthesia is commonly used. Pressure, brief discomfort or tenderness may occur. Pain experience varies, and any unexpected severe pain during or after injection requires prompt medical review.
The appointment is usually brief and performed as an outpatient procedure, but assessment and consent should not be rushed. Mild tenderness or spotting may occur. Dr. Shahane gives individual instructions about exercise, tampons and resuming intimacy.
Possible risks include pain, bleeding, bruising, swelling, infection, altered sensation, a palpable lump, asymmetry, urinary symptoms, painful intercourse, inflammatory reaction, migration or an unsatisfactory result. Rare serious complications have been reported after vaginal filler injections.
Any added volume from a resorbable filler is expected to be temporary, but duration varies with product, dose, tissue response and individual metabolism. A fixed duration should not be promised before consultation.
Yes. Enquiries, examination and records are handled privately. A female chaperone is arranged by default for intimate examination, and no examination or treatment proceeds without your explicit consent.
Choose the page that matches the actual concern rather than assuming one treatment fits every symptom.
Privacy-first overview of surgical and non-surgical female intimate care pathways.
Explore the hub → PRP optionLearn how PRP-based intimate injections differ from filler-based volume augmentation.
Compare the procedure → AssessmentA broad consultation pathway for childbirth, ageing, tissue and wellness concerns.
View the guide → Tissue laxityOptions for patients primarily concerned about laxity rather than focal sensitivity.
View treatment options → Urinary symptomsCause-focused evaluation for leakage with coughing, exercise or physical strain.
View the assessment page → Symptoms firstDischarge, irritation, odour or recurrent infection should be evaluated before cosmetic treatment.
Read the clinical guide →These sources support the page’s cautious framing. They do not establish guaranteed benefit from G-spot enhancement.
Medically reviewed: 03 August 2026. The review date should be changed only after a genuine clinical review.
A consultation can clarify whether a focal injection is reasonable, whether another assessment is more appropriate, or whether no procedure is the safest choice.
Mayflower Clinic is Central India's premier multi-specialty hub for advanced aesthetic and reconstructive plastic surgery. Every procedure is planned and executed exclusively by board-certified M.Ch. Plastic Surgeon Dr. Pawan Shahane, ensuring an absolute commitment to zero-delegation surgery, patient safety, and transparent pricing.

What Is Acne Scar Correction? A Complete…

Who Is a Good Candidate for Lip…
Clinic Address: Surdham Complex, Behind Silver Palace Building, 2nd Lane from Panchsheel Square, Opp. Yashwant Stadium, Dhantoli, Nagpur, Maharashtra - 440012
Landline Connect: 0712-6692706 / 0712-3551170
Secure WhatsApp Line: +91 8087471244
